News
- Author:
- Heidi Splete
Publish date: September 28, 2022
Nonspecific symptoms of IPF may prompt primary care providers to pursue other assessment pathways.
News
- Author:
- Heidi Splete
Publish date: September 26, 2022
A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
News
- Author:
- Heidi Splete
Publish date: September 23, 2022
Patients with CAP were less likely to progress to mechanical ventilation after corticosteroid therapy.
News
- Author:
- Heidi Splete
Publish date: September 23, 2022
Asthma patients who practiced mindfulness experienced significant improvement in symptoms.
News
- Author:
- Heidi Splete
Publish date: September 23, 2022
SSRIs were less effective in depressed patients with high C-reactive protein levels than in those with low levels.
News
- Author:
- Heidi Splete
Publish date: September 21, 2022
National Institute for Health Care Management panelists advocate partnerships between hospitals and community centers to ease barriers to access an...
News
- Author:
- Heidi Splete
Publish date: September 20, 2022
In December 2021, tralokinumab was approved for adults with moderate to severe AD in the United States, where it is marketed as Adbry.
News
- Author:
- Heidi Splete
Publish date: September 19, 2022
High-resolution manometry showed increased dysmotility in patients with higher measures of airway reflux.
News
- Author:
- Heidi Splete
Publish date: September 15, 2022
Successful extubations were similar for patients on inhaled vasodilators using nitric oxide and epoprostenol in a comparison study.
News
- Author:
- Heidi Splete
Publish date: September 13, 2022
Racial disparities remained but were lower in the pandemic period, compared with previous prepandemic studies.
News
- Author:
- Heidi Splete
Publish date: September 12, 2022
Approval was based on the results of two phase 3 trials of almost 1,700 adults with moderate to severe plaque psoriasis.
News
- Author:
- Heidi Splete
Publish date: September 9, 2022
Long-term follow-up data showed predictive value of dyskinesia and neurological soft signs for neuromotor dysfunction.
News
- Author:
- Heidi Splete
Publish date: September 9, 2022
Two-thirds of providers reported receiving no education on emergency contraception, despite relevance to isotretinoin patients.
News
- Author:
- Heidi Splete
Publish date: September 9, 2022
Local and systemic reactions, such as aches and pains, from a COVID-19 booster or third dose were short-lived with no ongoing concerns in pregnant ...
News
- Author:
- Heidi Splete
Publish date: September 2, 2022
Dolutegravir-based ART yields similar birth outcomes to other ART options.
